You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
《沪深股市》上证3,300点得而复失 深成倒跌 生物医药股逆市续升
阿思达克 07-30 11:30
人行今日将进行500亿元人民币(下同)7天期逆回购操作,并开展50亿元票据互换操作。人汇上升,上证深成今早高开後反覆,上证一度重返3,300点水平,惟缺乏承接下得而复失。

上证半日微升3点,收报3,297点;深成倒跌27点或0.2%,收报13,529点;创业板指数平收报2,767点。沪深两市成交分别3,014亿元及3,919亿元。

金融股国寿(601628.SH)跌1.5%。券商股个别发展,中信建投(601066.SH)、招商证券(600999.SH)、西南证券(600369.SH)跌1.2%-2.3%。财通证券(601108.SH)涨停。

农业股回升,万向德农(600371.SH)、登海种业(002041.SZ)分别升6.6%及3.1%。

生物医药股造好,双林生物(000403.SZ)、天坛生物(600161.SH)、神州细胞(688520.SH)升2.3%-5.7%。另外,国药股份(600511.SH)升5.5%。

芯片相关股回软,风华高科(000636.SZ)、彩讯股份(300634.SH)、晶方科技(603005.SH)跌1.2%-2.1%。

贵州茅台(600519.SH)半日升1.1%。(ta/u) ~

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account